Paul E Schulz

Paul E. Schulz, M.D., P.A. is a professional clinical and research entity led by Dr. Paul E. Schulz, a renowned neurologist and the Rick McCord Professor in Neurology at UTHealth Houston. The entity specializes in the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease and various forms of dementia. As a premier clinical research site, it serves as a principal investigator for numerous global Phase 2 and Phase 3 clinical trials evaluating novel disease-modifying therapies. The practice is deeply involved in the development of amyloid-targeting monoclonal antibodies and tau-focused interventions. Dr. Schulz's research also emphasizes the use of advanced neuroimaging and fluid biomarkers to enhance early detection and therapeutic monitoring. Located in the Texas Medical Center, the entity bridges the gap between academic innovation and pharmaceutical development to advance care for patients with cognitive impairment.